334 related articles for article (PubMed ID: 11801559)
21. Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.
Lin AL; White M; Miller-Thomas MM; Fulton RS; Tsien CI; Rich KM; Schmidt RE; Tran DD; Dahiya S
J Neurooncol; 2016 Dec; 130(3):529-533. PubMed ID: 27704386
[TBL] [Abstract][Full Text] [Related]
22. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment.
Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
[TBL] [Abstract][Full Text] [Related]
23. 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas.
Ichimura K; Vogazianou AP; Liu L; Pearson DM; Bäcklund LM; Plant K; Baird K; Langford CF; Gregory SG; Collins VP
Oncogene; 2008 Mar; 27(14):2097-108. PubMed ID: 17934521
[TBL] [Abstract][Full Text] [Related]
24. Deletion mapping of chromosome 19 in human gliomas.
von Deimling A; Nagel J; Bender B; Lenartz D; Schramm J; Louis DN; Wiestler OD
Int J Cancer; 1994 Jun; 57(5):676-80. PubMed ID: 8194874
[TBL] [Abstract][Full Text] [Related]
25. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors.
Sato K; Schäuble B; Kleihues P; Ohgaki H
Int J Cancer; 1996 May; 66(3):305-8. PubMed ID: 8621248
[TBL] [Abstract][Full Text] [Related]
26. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
Burns KL; Ueki K; Jhung SL; Koh J; Louis DN
J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetic analysis of giant cell glioblastomas.
Meyer-Puttlitz B; Hayashi Y; Waha A; Rollbrocker B; Boström J; Wiestler OD; Louis DN; Reifenberger G; von Deimling A
Am J Pathol; 1997 Sep; 151(3):853-7. PubMed ID: 9284834
[TBL] [Abstract][Full Text] [Related]
28. Exploiting nanopore sequencing for characterization and grading of IDH-mutant gliomas.
Wongsurawat T; Jenjaroenpun P; Anekwiang P; Arigul T; Thongrattana W; Jamshidi-Parsian A; Boysen G; Suriyaphol P; Suktitipat B; Srirabheebhat P; Cheunsuchon P; Tanboon J; Nookaew I; Sathornsumetee S
Brain Pathol; 2024 Jan; 34(1):e13203. PubMed ID: 37574201
[TBL] [Abstract][Full Text] [Related]
29. 1p/19q testing has no significance in the workup of glioblastomas.
Clark KH; Villano JL; Nikiforova MN; Hamilton RL; Horbinski C
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):706-17. PubMed ID: 23363074
[TBL] [Abstract][Full Text] [Related]
30. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma.
Ritland SR; Ganju V; Jenkins RB
Genes Chromosomes Cancer; 1995 Apr; 12(4):277-82. PubMed ID: 7539282
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of genomic abnormalities in human gliomas.
Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Cancer Genet Cytogenet; 1994 Apr; 73(2):122-9. PubMed ID: 8174086
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
Ransom DT; Ritland SR; Kimmel DW; Moertel CA; Dahl RJ; Scheithauer BW; Kelly PJ; Jenkins RB
Genes Chromosomes Cancer; 1992 Nov; 5(4):348-56. PubMed ID: 1283324
[TBL] [Abstract][Full Text] [Related]
33. The hPMS2 exon 5 mutation and malignant glioma. Case report.
Taylor MD; Perry J; Zlatescu MC; Stemmer-Rachamimov AO; Ang LC; Ino Y; Schwartz M; Becker LE; Louis DN; Cairncross JG
J Neurosurg; 1999 May; 90(5):946-50. PubMed ID: 10223463
[TBL] [Abstract][Full Text] [Related]
34. Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas.
Zhu JJ; Santarius T; Wu X; Tsong J; Guha A; Wu JK; Hudson TJ; Black PM
Genes Chromosomes Cancer; 1998 Mar; 21(3):207-16. PubMed ID: 9523195
[TBL] [Abstract][Full Text] [Related]
35. Spinal cord glioneuronal tumor with neuropil-like islands with 1p/19q deletion in an adult with low-grade cerebral oligodendroglioma.
Fraum TJ; Barak S; Pack S; Lonser RR; Fine HA; Quezado M; Iwamoto FM
J Neurooncol; 2012 Apr; 107(2):421-6. PubMed ID: 22083647
[TBL] [Abstract][Full Text] [Related]
36. New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26.
Maier D; Comparone D; Taylor E; Zhang Z; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1997 Aug; 15(8):997-1000. PubMed ID: 9285695
[TBL] [Abstract][Full Text] [Related]
37. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.
von Deimling A; Louis DN; von Ammon K; Petersen I; Hoell T; Chung RY; Martuza RL; Schoenfeld DA; Yaşargil MG; Wiestler OD
J Neurosurg; 1992 Aug; 77(2):295-301. PubMed ID: 1320666
[TBL] [Abstract][Full Text] [Related]
38. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.
Ichimura K; Schmidt EE; Miyakawa A; Goike HM; Collins VP
Genes Chromosomes Cancer; 1998 May; 22(1):9-15. PubMed ID: 9591629
[TBL] [Abstract][Full Text] [Related]
39. The molecular genetics of central nervous system tumors.
Ng HK; Lam PY
Pathology; 1998 May; 30(2):196-202. PubMed ID: 9643506
[TBL] [Abstract][Full Text] [Related]
40. Clonal analysis of gliomas.
Kattar MM; Kupsky WJ; Shimoyama RK; Vo TD; Olson MW; Bargar GR; Sarkar FH
Hum Pathol; 1997 Oct; 28(10):1166-79. PubMed ID: 9343324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
